This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Michael Torres
Director of Biology, coFounder at ReCode Therapeutics


Dr. Michael Torres is a co-founder of ReCode Therapeutics where he holds the position of Vice President of R&D. Dr. Torres leads ReCode’s drug discovery, platform validation, and pre-clinical development of novel candidates for genetic diseases such as cystic fibrosis and primary ciliary dyskinesia and is integral to company financing, defining program budgets, and business development activities. Prior to ReCode, Dr, Torres completed his post-doctoral training in Physiology at UT Southwestern Medical Center, where he also received his PhD in Cancer Biology.

Agenda Sessions

  • Panel Discussion: Deals that matter: Partnering with platform technologies: Trends, models and challenges.